Collectively, the above data gleaned from a diverse array of patient-based genomic, transcriptomic and protein datasets show that SKP1 is frequently misexpressed in human cancers, which suggests aberrant SKP1 expression may harbor tumor suppressive or oncogenic functions depending on whether it is under- or over-expressed, respectively. This evidence concerns the gene SKP1 and cancer.